Medical Equipment

A key trend shaping the Polyp Biopsy Market involves the Cloud-Based AI Transforms Real-Time Detection in Colorectal Screening

March 16, 2026April 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Polyp Biopsy Market Over The Period 2026–2030?

The polyp biopsy market size has demonstrated strong growth in recent years. It is anticipated to increase from $1.39 billion in 2025 to $1.5 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.5%. The expansion observed historically stems from a confluence of factors, including the rising prevalence of gastrointestinal and cervical cancers, advancements in endoscopic technologies, the proliferation of screening programs, heightened awareness regarding the benefits of early diagnosis, and the establishment of specialty clinics.

The polyp biopsy market size anticipates robust expansion in the coming years. This market is projected to reach $2.06 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 8.2%. This anticipated growth during the forecast period is fueled by factors such as AI-assisted biopsy procedures, the adoption of minimally invasive techniques, the increasing embrace by hospitals and diagnostic laboratories, seamless integration with imaging and cloud platforms, and the creation of innovative biopsy tools. Key trends influencing the forecast period encompass colonoscopy biopsy, colposcopy-directed biopsy, esophagogastroduodenoscopy biopsy, laryngoscopy biopsy, and endoscopic mucosal resection (EMR).

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28304&type=smp

What Drivers Are Expected To Influence The Polyp Biopsy Market During The Forecast Period?

The escalating occurrence of colorectal cancer is anticipated to drive the expansion of the polyp biopsy market. Colorectal cancer, a malignant disease that emerges in the colon or rectum due to the abnormal, uncontrolled proliferation of epithelial cells lining the large intestine, has the capacity to invade nearby tissues and spread to distant organs. The increasing prevalence of this cancer is primarily attributed to prevalent dietary habits characterized by high consumption of processed foods and insufficient fiber, which foster chronic inflammation, modify the gut microbiota, and facilitate the development of precancerous lesions that can advance to malignancy over time. Polyp biopsy plays a vital role in mitigating the impact of rising colorectal cancer by enabling the early detection and histopathological assessment of suspicious lesions, thereby supporting timely intervention and preventing the disease from progressing. For example, the American Cancer Society (ACS), a US-based non-profit organization, projects that in 2025, approximately 107,320 new cases of colon cancer and 46,950 cases of rectal cancer will be diagnosed in the United States, with an estimated 52,900 deaths resulting from these cancers. Consequently, the growing prevalence of colorectal cancer is a significant factor propelling the growth of the polyp biopsy market.

How Is The Polyp Biopsy Market Divided Into Its Major Segments?

The polyp biopsy market covered in this report is segmented –

1) By Type: Colonoscopy, Colposcopy-Directed Biopsy, Esophagogastroduodenoscopy

2) By Technique: Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD), Conventional Biopsy

3) By Application: Colorectal Cancer, Gastrointestinal Disorders, Other Applications

4) By End-User: Hospitals, Specialty Clinics

Subsegments:

1) By Colonoscopy: Diagnostic Colonoscopy, Therapeutic Colonoscopy

2) By Colposcopy-Directed Biopsy: Cervical Biopsy, Vaginal Biopsy, Vulvar Biopsy

3) By Esophagogastroduodenoscopy: Diagnostic Esophagogastroduodenoscopy, Therapeutic Esophagogastroduodenoscopy

How Are Trends Transforming The Polyp Biopsy Market Landscape?

Leading firms within the polyp biopsy market are concentrating on developing advanced innovations, such as AI-driven detection technologies, to improve the identification of colorectal polyps and facilitate the prompt discovery of potential cancerous lesions. An AI-driven detection system functions by analyzing medical images in real-time to spot possible anomalies and alert clinicians visually, thereby assisting clinical decision-making without requiring therapeutic procedures. For instance, in September 2024, Odin Medical Ltd., a US-based medical technology company associated with Olympus Corporation, introduced CADDIE, its cloud-powered AI endoscopic system. The CADDIE device utilizes cloud-based artificial intelligence to process colonoscopy video footage instantly, highlighting regions where colorectal polyps are suspected, which empowers endoscopists to make well-informed choices during interventions. Clinical studies demonstrated that this system enhances the adenoma detection rate without extending procedural duration or risk, emphasizing its capacity to improve early diagnosis and patient outcomes.

Who Are The Prominent Organizations Shaping The Polyp Biopsy Market?

Major companies operating in the polyp biopsy market are Johnson & Johnson (Ethicon), Medtronic plc, Medline Industries LP, FUJIFILM Holdings Corporation, Stryker Corporation, Becton Dickinson and Company (BD), Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, STERIS plc, Hologic Inc., CooperSurgical Inc., KARL STORZ SE & Co. KG, Cook Medical, ConMed Corporation, Ambu A/S, Richard Wolf GmbH, INRAD, Acheron Instruments (Pvt) Ltd., Innovia Medical

Read the full polyp biopsy market report here:

https://www.thebusinessresearchcompany.com/report/polyp-biopsy-global-market-report

Which Region Is Forecast To Lead The Polyp Biopsy Market In Terms Of Market Size?

North America was the largest region in the polyp biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polyp biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Polyp Biopsy Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28304&type=smp

Browse Through More Reports Similar to the Global Polyp Biopsy Market 2026, By The Business Research Company

Kidney Biopsy Market Report 2026

https://www.thebusinessresearchcompany.com/report/kidney-biopsy-global-market-report

Liquid Biopsy For Cancer Diagnostics Market Report 2026

https://www.thebusinessresearchcompany.com/report/liquid-biopsy-for-cancer-diagnostics-global-market-report

Biopsy Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopsy-devices-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795